About Avinger
Avinger is a company based in Redwood City (United States) founded in 2007. Avinger has raised $170.85 million across 10 funding rounds from investors including Zylox-Tonbridge, CRG and PDL BioPharma. Avinger offers products and services including Pantheris, Ocelot, TigerEye, and Lightbox. Avinger operates in a competitive market with competitors including Pathway Medical Technologies, Intact Vascular, LeMaitre Vascular, Cagent Vascular and Okami Medical, among others.
- Headquarter Redwood City, United States
- Stage Public
- SectorsHealthcare
- Website avinger.com
- Social LinkedIn X Facebook YouTube
- Total Equity Funding$170.85M (USD)
in 10 rounds
- Latest Funding Round$15M (USD), Post-IPO
Mar 2024
- InvestorsZylox-Tonbridge
& 2 more
Products & Services of Avinger
Avinger offers a comprehensive portfolio of products and services, including Pantheris, Ocelot, TigerEye, and Lightbox.
Image-guided tool for directional atherectomy in vascular disease.
Device for crossing chronic total occlusions with real-time imaging.
Provides onboard imaging for precise vascular interventions.
Console for operating image-guided vascular devices.
Apps and channels of Avinger
its YouTube channel Avinger has 1.12K subscribers and 30 videos.
Videos from Avinger
The most watched videos on Avinger's YouTube channel, Avinger (1.12K subscribers). Click a video to play it here.
More on Avinger.
Funding Insights of Avinger
Avinger has successfully raised a total of $170.85M across 10 strategic funding rounds. The most recent funding activity was a Post-IPO round of $15 million completed in March 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $170.85M
- Total Rounds 10
- Last Round Post-IPO — $15M
- First Round $24.23M
(Dec 2010)
- Investors Count 3
All 10 funding rounds of Avinger with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2024 | $15M | Post-IPO | – | – | |
| Mar 2022 | – | Post-IPO | – | – | – |
| Sep 2014 | $34.83M | Series E | – | – | |
| Nov 2013 | $10.47M | Series D | – | – | – |
| Apr 2013 | $20M | Debt – Conventional | – | – | |
| Jul 2012 | $32.67M | Series D | – | – | – |
| Jan 2012 | $22.5M | Series C | – | – | – |
| Sep 2011 | $21.15M | Series B | – | – | – |
| Jan 2011 | $25M | Series B | – | – | – |
| Dec 2010 | $24.23M | Series A | – | – | – |
3 investors in total: 3 institutional.
Investors in Avinger
Avinger has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Zylox-Tonbridge, CRG and PDL BioPharma.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
CRG is recognized as a premier healthcare investment partner. | – | crglp.com | Houston, United States | |
Biopharmaceutical company undergoing dissolution and asset distribution processes. | – | pdl.com | - | |
Medical equipment is manufactured by Zylox-Tonbridge in Hangzhou, China. | 2012 | zyloxtb.com | Hangzhou, China |
Investor details for Avinger
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Avinger
8 people are tracked at Avinger (5 in leadership, 3 in board & advisors).
| Name | Role | Group |
|---|---|---|
Thomas Lawson | Vice President, Clinical & Regulatory Affairs | Leadership |
Himanshu Patel | CTO | Leadership |
Jay Sundaram | Vice President of Quality & Management Representative | Leadership |
Jeffrey M. Soinski | CEO | Leadership |
Phil Preuss | Vice President, Marketing & Business Operations | Leadership |
James G. Cullen | Chairman | Board & advisors |
James B. Mcelwee | Director | Board & advisors |
Tamara Elias | Director | Board & advisors |
Complete people profiles for Avinger
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Avinger
4 dated milestones of Avinger across 17 years, from founding to its latest funding, stage changes and deals.
- Founded Avinger is founded.
- Funding First funding round of $24.2M.
- IPO Lists on the stock exchange (IPO).
- Funding Latest funding round, Post-IPO, of $15.0M.
Competitors of Avinger
Avinger operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Pathway Medical Technologies, Intact Vascular, LeMaitre Vascular, Cagent Vascular and Okami Medical, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| pathwaymedical.com | 1998 | Kirkland, United States | $101.93M | 158 | Smart devices are provided to clear peripheral arterial blockages. | |
| intactvascular.com | 2011 | Wayne, United States | $123.4M | 64 | Implants for repairing arteries after angioplasty are developed. | |
| lemaitre.com | 1983 | Burlington, United States | $5.83M | 317 | Devices for peripheral vascular disease treatment are developed and marketed. | |
| cagentvascular.com | 2014 | Wayne, United States | $69.42M | – | Devices for removing vascular blockages are developed. | |
| okamimedical.com | 2011 | Aliso Viejo, United States | $62.09M | – | Innovative medical devices for peripheral vessel treatment are developed. | |
| venturemedgroup.com | 2012 | Toledo, United States | $51.05M | – | Endovascular devices are developed for PAD and AV fistula treatments. | |
| truvic.com | 2014 | Campbell, United States | $5.89M | – | Smart devices for peripheral vascular thrombus management are developed. | |
| ramed.com | 2002 | Carlsbad, United States | $24.29M | 14 | Excimer lasers for skin and vascular disease treatments are developed. | |
| versono.life | 2019 | Galway, Ireland | $7.05M | – | Therapeutic solutions for peripheral arterial disease are developed by Versono. |
Detailed competitors of Avinger
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Avinger
The website of Avinger (avinger.com) receives about 1.9K visits a month.
- Monthly visits1.9K
▲ 13.5% vs previous month
Latest news on Avinger
Complete news archive for Avinger
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Avinger
10 companies that operate in the same segment as Avinger (Cardiac and Vascular Disorders), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Connected devices for health, sleep, and activity monitoring are developed. | 2008 | Moulineaux, Seine-maritime, France | USD 93.83 M | – | – | |
SMT is recognized as a developer of cardiovascular medical devices. | 1998 | Surat, Gujarat, India | USD 57.22 M | USD 106.25 M | 1,090 | |
Gene-editing therapies for coronary artery disease are developed. | 2018 | Cambridge, Massachusetts, United States | USD 215.5 M | – | 255 | |
Cardiac monitoring devices and applications are provided for heart health. | 2010 | Mountain View, California, United States | USD 114.38 M | USD 6.18 M | 67 | |
Therapies for lowering low-density lipoprotein cholesterol levels are developed. | 1998 | Ann Arbor, Michigan, United States | USD 129.7 M | USD 332.31 M | 304 | |
Cloud-based ambulatory ECG monitors for cardiac arrhythmia diagnosis are provided. | 2006 | San Francisco, California, United States | USD 109.23 M | USD 747.14 M | 2,000 | |
Provider of neuroprotection devices for carotid artery disease | 2007 | Sunnyvale, California, United States | USD 241.8 M | – | – | |
Miniaturized wireless implantable sensors are developed for hemodynamic monitoring. | 2007 | East Peoria, Illinois, United States | USD 154.77 M | – | 104 | |
Access catheters for neurovascular stroke treatment are provided. | 2015 | Campbell, California, United States | USD 596 M | – | – | |
Biosensor patches are developed for monitoring multiple body vitals. | 2011 | Campbell, California, United States | USD 239.95 M | – | 184 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Avinger
Avinger was founded in 2007 and raised its 1st funding round 3 years after it was founded.
Avinger is headquartered in Redwood City, United States. It is registered at Redwood City, California, United States.
Avinger is a funded company, having raised a total of $170.85M across 10 funding rounds to date. The company's 1st funding round was a Series A of $24.23M, raised on Dec 2010.
Avinger was founded in 2007 as a commercial-stage medical device company based in Redwood City, United States. Catheter-based products guided by imaging technology are developed, manufactured, and sold for the treatment of peripheral artery disease. The product range includes the Lightbox imaging console and catheters such as Wildcat, Kittycat, and Ocelot, supporting interventions in the vascular sector.
Avinger's top competitors include Okami Medical, Cagent Vascular and LeMaitre Vascular.
Avinger offers Pantheris, Ocelot, TigerEye, and Lightbox.
Avinger has 3 investors. Key investors include Zylox-Tonbridge, CRG, and PDL BioPharma.